The diabetes pandemic suggests unmet needs for ‘CKD with diabetes’ in addition to ‘diabetic nephropathy’–implications for pre-clinical research and drug testing
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The diabetes pandemic suggests unmet needs for ‘CKD with diabetes’ in addition to ‘diabetic nephropathy’–implications for pre-clinical research and drug testing
Authors
Keywords
-
Journal
NEPHROLOGY DIALYSIS TRANSPLANTATION
Volume -, Issue -, Pages -
Publisher
Oxford University Press (OUP)
Online
2017-05-23
DOI
10.1093/ndt/gfx219
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Glomerular Hyperfiltration in Diabetes: Mechanisms, Clinical Significance, and Treatment
- (2017) Lennart Tonneijck et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Kidney disease and obesity: epidemiology, mechanisms and treatment
- (2017) Niels Olsen Saraiva Câmara et al. Nature Reviews Nephrology
- American Diabetes Association Standards of Medical Care in Diabetes 2017
- (2017) Payal H. Marathe et al. Journal of Diabetes
- Estimation of chronic kidney disease incidence from prevalence and mortality data in American Indians with type 2 diabetes
- (2017) Pavithra Vijayakumar et al. PLoS One
- Olmesartan Prevents Microalbuminuria in db/db Diabetic Mice Through Inhibition of Angiotensin II/p38/SIRT1-Induced Podocyte Apoptosis
- (2016) Junhui Gu et al. KIDNEY & BLOOD PRESSURE RESEARCH
- An autopsy study suggests that diabetic nephropathy is underdiagnosed
- (2016) Celine Q.F. Klessens et al. KIDNEY INTERNATIONAL
- Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
- (2016) Christoph Wanner et al. NEW ENGLAND JOURNAL OF MEDICINE
- Beneficial Effects of Sarpogrelate and Rosuvastatin in High Fat Diet/Streptozotocin-Induced Nephropathy in Mice
- (2016) Dong-hyun Kim et al. PLoS One
- The Mechanisms and Therapeutic Potential of SGLT2 Inhibitors in Diabetes Mellitus
- (2015) Volker Vallon Annual Review of Medicine
- Cathepsin S Cleavage of Protease-Activated Receptor-2 on Endothelial Cells Promotes Microvascular Diabetes Complications
- (2015) S. Kumar VR et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Glomerular Aging and Focal Global Glomerulosclerosis: A Podometric Perspective
- (2015) J. B. Hodgin et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Diabetic nephropathy: landmark clinical trials and tribulations
- (2015) Gary C.W. Chan et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- The effect of CCR2 inhibitor CCX140-B on residual albuminuria in patients with type 2 diabetes and nephropathy: a randomised trial
- (2015) Dick de Zeeuw et al. Lancet Diabetes & Endocrinology
- Renal Biopsy in Type 2 Diabetic Patients
- (2015) Eugenia Espinel et al. Journal of Clinical Medicine
- Glycemic control with empagliflozin, a novel selective SGLT2 inhibitor, ameliorates cardiovascular injury and cognitive dysfunction in obese and type 2 diabetic mice
- (2014) Bowen Lin et al. Cardiovascular Diabetology
- Combination therapy with spironolactone and candesartan protects against streptozotocin-induced diabetic nephropathy in rats
- (2014) Amal Hofni et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Effect of Insulin on ACE2 Activity and Kidney Function in the Non-Obese Diabetic Mouse
- (2014) Marta Riera et al. PLoS One
- A Novel Mouse Model of Advanced Diabetic Kidney Disease
- (2014) Jean-Francois Thibodeau et al. PLoS One
- Valsartan slows the progression of diabetic nephropathy indb/dbmice via a reduction in podocyte injury, and renal oxidative stress and inflammation
- (2013) Guangyu Zhou et al. CLINICAL SCIENCE
- Design of the Nephrotic Syndrome Study Network (NEPTUNE) to evaluate primary glomerular nephropathy by a multidisciplinary approach
- (2013) Crystal A. Gadegbeku et al. KIDNEY INTERNATIONAL
- Efficacy and safety of canagliflozin versus glimepiride in patients with type 2 diabetes inadequately controlled with metformin (CANTATA-SU): 52 week results from a randomised, double-blind, phase 3 non-inferiority trial
- (2013) William T Cefalu et al. LANCET
- Combined Angiotensin Inhibition for the Treatment of Diabetic Nephropathy
- (2013) Linda F. Fried et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sulodexide Decreases Albuminuria and Regulates Matrix Protein Accumulation in C57BL/6 Mice with Streptozotocin-Induced Type I Diabetic Nephropathy
- (2013) Susan Yung et al. PLoS One
- Accelerated renal disease is associated with the development of metabolic syndrome in a glucolipotoxic mouse model
- (2012) C. Martinez-Garcia et al. Disease Models & Mechanisms
- Add-On Aliskiren Elicits Stronger Renoprotection Than High-Dose Valsartan in Type 2 Diabetic KKAy Mice That Do Not Respond to Low-Dose Valsartan
- (2012) Bai Lei et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
- Glomerular hyperfiltration: definitions, mechanisms and clinical implications
- (2012) Imed Helal et al. Nature Reviews Nephrology
- Cardiorenal End Points in a Trial of Aliskiren for Type 2 Diabetes
- (2012) Hans-Henrik Parving et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of Canagliflozin on Renal Threshold for Glucose, Glycemia, and Body Weight in Normal and Diabetic Animal Models
- (2012) Yin Liang et al. PLoS One
- A Glimpse of Various Pathogenetic Mechanisms of Diabetic Nephropathy
- (2011) Yashpal S. Kanwar et al. Annual Review of Pathology-Mechanisms of Disease
- Renal Function in Diabetic Disease Models: The Tubular System in the Pathophysiology of the Diabetic Kidney
- (2011) Volker Vallon et al. Annual Review of Physiology
- Effects of olmesartan on renal and cardiovascular outcomes in type 2 diabetes with overt nephropathy: a multicentre, randomised, placebo-controlled study
- (2011) E. Imai et al. DIABETOLOGIA
- Sulodexide Fails to Demonstrate Renoprotection in Overt Type 2 Diabetic Nephropathy
- (2011) D. K. Packham et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- An orally active chemokine receptor CCR2 antagonist prevents glomerulosclerosis and renal failure in type 2 diabetes
- (2011) Sufyan G. Sayyed et al. KIDNEY INTERNATIONAL
- Glomerular hyperfiltration and increased glomerular filtration surface are associated with renal function decline in normo- and microalbuminuric type 2 diabetes
- (2011) Tatsumi Moriya et al. KIDNEY INTERNATIONAL
- Bardoxolone Methyl and Kidney Function in CKD with Type 2 Diabetes
- (2011) Pablo E. Pergola et al. NEW ENGLAND JOURNAL OF MEDICINE
- Olmesartan for the Delay or Prevention of Microalbuminuria in Type 2 Diabetes
- (2011) Hermann Haller et al. NEW ENGLAND JOURNAL OF MEDICINE
- Renal Failure Increases Cardiac Histone H3 Acetylation, Dimethylation, and Phosphorylation and the Induction of Cardiomyopathy-Related Genes in Type 2 Diabetes
- (2010) Anil Bhanudas Gaikwad et al. AMERICAN JOURNAL OF PATHOLOGY
- Phase 1 Study of Anti-CTGF Monoclonal Antibody in Patients with Diabetes and Microalbuminuria
- (2010) S. G. Adler et al. Clinical Journal of the American Society of Nephrology
- Aliskiren enhances protective effects of valsartan against type 2 diabetic nephropathy in mice
- (2010) Yi-Fei Dong et al. JOURNAL OF HYPERTENSION
- BTBR Ob/Ob Mutant Mice Model Progressive Diabetic Nephropathy
- (2010) K. L. Hudkins et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Avosentan for Overt Diabetic Nephropathy
- (2010) J. F.E. Mann et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Angiotensin II overcomes strain-dependent resistance of rapid CKD progression in a new remnant kidney mouse model
- (2010) Asada Leelahavanichkul et al. KIDNEY INTERNATIONAL
- Progressive glomerulosclerosis in type 2 diabetes is associated with renal histone H3K9 and H3K23 acetylation, H3K4 dimethylation and phosphorylation at serine 10
- (2010) Sufyan G. Sayyed et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Sulodexide ameliorates early but not late kidney disease in models of radiation nephropathy and diabetic nephropathy
- (2010) M. Rossini et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Effect of Valsartan on the Incidence of Diabetes and Cardiovascular Events
- (2010) NEW ENGLAND JOURNAL OF MEDICINE
- The endothelin receptor antagonist avosentan ameliorates nephropathy and atherosclerosis in diabetic apolipoprotein E knockout mice
- (2009) A. M. D. Watson et al. DIABETOLOGIA
- Podocytes produce homeostatic chemokine stromal cell-derived factor-1/CXCL12, which contributes to glomerulosclerosis, podocyte loss and albuminuria in a mouse model of type 2 diabetes
- (2009) S. G. Sayyed et al. DIABETOLOGIA
- Is hyperfiltration associated with the future risk of developing diabetic nephropathy? A meta-analysis
- (2009) G. M. Magee et al. DIABETOLOGIA
- Mouse Models of Diabetic Nephropathy
- (2009) F. C. Brosius et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Late Onset of Ccl2 Blockade with the Spiegelmer mNOX-E36–3′PEG Prevents Glomerulosclerosis and Improves Glomerular Filtration Rate in db/db Mice
- (2008) Volha Ninichuk et al. AMERICAN JOURNAL OF PATHOLOGY
- Effects of Aliskiren on Blood Pressure, Albuminuria, and (Pro)Renin Receptor Expression in Diabetic TG(mRen-2)27 Rats
- (2008) David L. Feldman et al. HYPERTENSION
- Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial
- (2008) Johannes FE Mann et al. LANCET
- Amelioration of diabetic tubulointerstitial damage in liver-type fatty acid-binding protein transgenic mice
- (2008) Atsuko Kamijo-Ikemori et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Aliskiren Combined with Losartan in Type 2 Diabetes and Nephropathy
- (2008) Hans-Henrik Parving et al. NEW ENGLAND JOURNAL OF MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started